Longer term effects of early dietary cholesterol level on synthesis and circulating cholesterol concentrations in

Timothy M Bayley1, Mahmood Alasmi, Thor Thorkelson

  • 1School of Dietetics and Human Nutrition, Macdonald Campus of McGill University, Ste-Anne-de Bellevue, Quebec, Canada.

Insights

Early infant diet has minimal impact on cholesterol synthesis later in life. Cholesterol homeostasis in infants shows resilience to dietary changes, suggesting limited long-term effects on cholesterol metabolism.

Area of Science:

  • Pediatrics
  • Nutritional Science
  • Biochemistry

Background:

  • Infant cholesterol homeostasis is crucial for long-term cardiovascular health.
  • Early life adaptive mechanisms may influence adult cholesterol levels.
  • Dietary cholesterol intake during infancy is a variable factor.

Purpose of the Study:

  • To investigate the long-term effects of infant dietary cholesterol supplementation on cholesterol homeostasis.
  • To assess the responsiveness of endogenous cholesterol synthesis to dietary cholesterol.
  • To examine potential imprinting effects of early diet on cholesterol metabolism.

Main Methods:

  • Studied 81 healthy neonates across three feeding groups: breast-fed (BF), regular formula (RF), and RF with added cholesterol (RF+cholesterol).
  • Measured cholesterol fractional synthetic rate (FSR) using deuterium incorporation at 4, 11, and 12 months.
  • Administered a 1-month cholesterol challenge at 11 months in a cross-over design for a subset of infants.

Main Results:

  • Plasma total- and LDL-cholesterol were higher in BF infants at 4 months compared to formula-fed groups.
  • Cholesterol fractional synthetic rate (FSR) was significantly higher in formula-fed infants (RF and RF+cholesterol) compared to BF infants at 4 months.
  • No significant differences in FSR were observed between RF and RF+cholesterol groups, or before and after the cholesterol challenge.
  • Synthesis rates increased in BF infants and decreased in formula-fed infants from 4 to 12 months.

Conclusions:

  • Infant cholesterol synthesis and serum concentrations show relative insensitivity to dietary cholesterol challenges.
  • Early dietary cholesterol intake appears to have minimal lasting effects on cholesterol metabolism in young infants.
  • Cholesterol homeostasis mechanisms in infants are robust and adaptively regulate synthesis rates regardless of early dietary exposure.

Related Concept Videos

Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...